About Diasorin (OTCMKTS:DSRLF)
DiaSorin S.p.A. engages in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in various clinical areas in the market of immunodiagnostics and molecular diagnostics. The company offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; gastrointestinal infections; autoimmunity; and cardiac and brain damages. Its immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; ETI Max 3000, an automated microtiter plate analyzer; EVOlyzer 2-150/8 with disposable tips; and ELISA washers and readers. The company also offers molecular diagnostic products for oncology, hematology, and infectious diseases; systems, including LIAISON IXT and BULLET Pro to extract the nucleic acid from various biological samples; and LIAISON IAM to diagnose and monitor various infectious diseases and onco-hematology parameters. It sells its products directly, as well as through an international network of independent distributors in Europe, Africa, Central America, South America, the Asia Pacific, and North America. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E Ratio28.60
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Diasorin (OTCMKTS:DSRLF) Frequently Asked Questions
What is Diasorin's stock symbol?
Diasorin trades on the OTCMKTS under the ticker symbol "DSRLF."
Who are some of Diasorin's key competitors?
Some companies that are related to Diasorin include IPSEN (IPSEY), H. Lundbeck A/S- (HLUYY), WellCare Health Plans (WCG), Seattle Genetics (SGEN), Jazz Pharmaceuticals (JAZZ), Alkermes (ALKS), Nmc Health (NMHLY), Bio-Rad Laboratories (BIO), Steris (STE), West Pharmaceutical Services (WST), William Demant Hol (WILYY), Sage Therapeutics (SAGE), Valeant Pharmaceuticals International (VRX), Ionis Pharmaceuticals (IONS), Juno Therapeutics (JUNO), Neurocrine Biosciences (NBIX), United Therapeutics (UTHR) and Stada Arzneimittel (STDAF).
How do I buy Diasorin stock?
Shares of Diasorin can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Diasorin's stock price today?
One share of Diasorin stock can currently be purchased for approximately $90.94.
How big of a company is Diasorin?
Diasorin has a market capitalization of $5.09 billion.
How can I contact Diasorin?
Diasorin's mailing address is Via Crescentino, Saluggia L6, 13040. The company can be reached via phone at 390-161-4871 or via email at [email protected]
MarketBeat Community Rating for Diasorin (DSRLF)MarketBeat's community ratings are surveys of what our community members think about Diasorin and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Diasorin (OTCMKTS:DSRLF) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Diasorin (OTCMKTS:DSRLF)
No earnings announcements for this company have been tracked by MarketBeat.com
Diasorin (OTCMKTS:DSRLF) Earnings Estimates
Current Year EPS Consensus Estimate: $3.18 EPS
Next Year EPS Consensus Estimate: $3.58 EPS
Dividend History for Diasorin (OTCMKTS:DSRLF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Diasorin (OTCMKTS DSRLF)
No insider trades for this company have been tracked by MarketBeat.com
Diasorin (OTCMKTS DSRLF) News Headlines
Diasorin (OTCMKTS:DSRLF) SEC Filings
Financials are not available for this stock.
Diasorin (OTCMKTS DSRLF) Stock Chart for Monday, December, 11, 2017